Video Scripts
Scripts written to be spoken, not read. Short sentences, a strong hook in the first few seconds, and a clear structure that keeps viewers watching to the end.
Trump Signs Executive Order to Reschedule Cannabis: What It Really Means
YouTube
Published on YouTube as “Cannabis Schedule III Under Trump: What the U.S. Cannabis Industry Needs to Know.” Presented by Dr. Lucas McCann, Chief Scientific Officer at CannDelta.
Target audience
Cannabis business owners, operators, investors, and industry professionals in the U.S., plus patients and researchers following federal cannabis policy.
Tone
Clear, measured, and conversational. Written for an expert presenter to speak on camera, balanced enough to cover both supporters and opponents.
Goal
Explain what the executive order does and doesn’t change, position CannDelta as the go-to regulatory expert, and invite viewers to reach out for compliance support.
How I built it
- About 800 words, roughly five minutes on camera
- A hook that states the news and corrects the biggest misconception within the first 30 seconds
- One idea per segment: research, Medicare, taxes, exports, and opposition
- Short recap lines that give viewers a takeaway after each segment
- A closing call to action for CannDelta’s compliance and regulatory services
So, is this a breakthrough? Yes! But it’s not the finish line.
Closing segment
The opening hook
For decades, cannabis has been classified by the federal government alongside the most dangerous substances in the United States. This week, that changed.
But before anyone jumps to conclusions, this is not federal legalization. So what actually changed, what didn’t, and why does this matter for patients, researchers, and the cannabis industry?
Hi, I’m Dr. Lucas McCann, Chief Scientific Officer at CannDelta, and today we’re breaking it all down.
How the script is structured
- What changed. Under this executive order, marijuana would move from Schedule I to Schedule III.
- Research. In short, research gets easier, but it’s not a silver bullet.
- Medicare pilot. This could be one of the most immediate, real-world impacts of the order.
- Taxes and 280E. From a business perspective, this is progress, not relief.
- Exports to Europe. This pathway mainly benefits pharmaceutical-focused cannabis companies, not traditional dispensary operators.
- Opposition. Trump’s order effectively pushes that process forward, despite resistance within his own party.
- The bottom line. For the cannabis industry, this is a meaningful but limited shift.